Universal Flu Vaccine Successfully Tested

Scientists at Oxford Jenner Institute have developed a universal flu vaccine that could protect against all known strains for up to 10 years. This vaccine uses internal proteins from the virus, which remain constant, unlike the outer proteins that change frequently. Early tests show promising results, suggesting that the vaccine could reduce the severity of flu and prevent pandemics. The vaccine could be administered at any time, reducing the seasonal rush for flu shots. Further studies are needed to confirm its effectiveness in a larger population.

What is the main advantage of the new universal flu vaccine discussed in the first section?

• It can be administered orally.

• It is cheaper than existing vaccines.

• It requires no booster shots.

• It is effective against all known strains for up to 10 years.

How does the new vaccine differ from existing flu vaccines in terms of its composition?

• It uses proteins from the outer coat of the virus.

• It uses internal proteins that remain constant across strains.

• It is a combination of multiple existing vaccines.

• It is made from live attenuated virus.

What is a potential benefit of the new vaccine in terms of public health?

• It will eliminate the need for any vaccinations.

• It will make flu a mild illness compared to today.

• It will completely eradicate the flu virus.

• It will increase the number of flu cases.

What is the expected impact of the new vaccine on the seasonal demand for flu shots?

• It will make flu shots available only in winter.

• It will have no impact on the demand for flu shots.

• It will reduce the seasonal rush for flu shots.

• It will increase the demand for flu shots in autumn.

What is the ultimate hope for the new vaccine according to the final section?

• To replace all existing vaccines.

• To be administered only once in a lifetime.

• To completely eradicate all viruses.

• To make flu a mild illness and prevent serious illness and deaths.